相关实验视频
Updated: Jun 23, 2025
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
阿拉姆霍尔改善了与代谢功能障碍相关的脂肪肝炎中的肝纤维化:使用传统和数字病理学的多模式评估结果
Vlad Ratziu1, Yusuf Yilmaz2,3, Don Lazas4
1Sorbonne Université, Institute for Cardiometabolism and Nutrition (ICAN) and Hôpital Pitié-Salpêtrière, INSERM UMRS 1138 CRC, Paris, France.
Hepatology (Baltimore, Md.)
|June 25, 2024
概括
数字图像分析提供了一种更敏感的方法,用于评估代谢功能障碍相关的脂肪肝炎试验中的抗纤维素药物疗效. 这种先进的技术为评估纤维化提供了比传统病理学更大的动态范围.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 数字病理学数字病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗纤维素临床试验传统上使用常规病理学,该病理学已认识到治疗效果量化的局限性.
- 代谢功能障碍相关的脂肪肝炎 (MASH) 越来越令人担忧,需要改进评估抗纤维菌疗法的方法.
研究的目的:
- 将单纤维数字图像分析与传统病理学进行比较,以量化Aramchol的抗纤维作用,这是一种新型的醇-CoA脱酶1抑制剂.
- 评估MASH患者纤维化评估的数字图像分析的灵敏度和动态范围.
主要方法:
- 在ARMOR试验中,51名MASH患者接受了Aramchol (300 mg两次),并配对治疗前后肝脏活检.
- 使用常规病理学 (NASH-CRN分期,排名对评估) 和数字图像分析平台 (PharmaNest) 来分析活检,生成连续纤维化复合严重性 (Ph-FCS) 评分.
- 纤维化改善是由NASH-CRN阶段减少,排名对评估或Ph-FCS得分变化来定义的.
主要成果:
- 纤维化改善率有所不同:31% (NASH-CRN),51% (排名对),74.5% (任何Ph-FCS减少) 和41% (显著的Ph-FCS减少).
- 数字图像分析检测到大多数具有稳定常规得分的患者的纤维化改善,改善与治疗持续时间相关.
- 通过减少肝硬性,Pro-C3和增强肝纤维化,证实了阿拉姆霍尔的抗纤维作用,Ph-FCS变化与肝硬性正相关.
结论:
- 与传统病理学相比,数字图像分析的连续纤维化得分提供了更高的灵敏度和更大的动态范围来量化抗纤维素效应.
- 数字图像分析代表了MASH中抗纤维菌药物开发的有希望的进步.
更多相关视频
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
01:24Chronic Pancreatitis I: Introduction
86
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
86
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
646
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
646
01:17Chronic Bowel Disorders: Introduction
440
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
440